GHK-CU vs GLOW

GHK-CU

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first isolated from human plasma by Pickart and Thaler in 1973. Its mechanism of action involves delivering bioavailable copper ions to tissues, where copper serves as a cofactor for lysyl oxidase (collagen crosslinking), superoxide dismutase (antioxidant defense), and other metalloenzymes critical for tissue maintenance. GHK-Cu modulates gene expression of over 4,000 human genes, broadly shifting patterns toward tissue remodeling and repair (Pickart et al., BioMed Research International, 2012). Research demonstrates it upregulates collagen types I and III, elastin, decorin, and glycosaminoglycan synthesis while simultaneously downregulating metalloproteinase activity that degrades extracellular matrix. In wound healing studies, GHK-Cu accelerated dermal wound contraction and re-epithelialization in animal models (Leyden et al., Archives of Dermatological Research, 2002). The peptide also shows neuroprotective properties; studies suggest it reduces oxidative damage markers and may support nerve regeneration through NGF and VEGF upregulation. Compared to retinoids and vitamin C in skin research, GHK-Cu operates through a fundamentally different mechanism centered on copper-dependent enzymatic activity and broad transcriptomic remodeling rather than receptor activation or direct antioxidant scavenging. At 100mg, this formulation supports extended research studies. Store lyophilized powder at -20C protected from light; reconstitute with sterile water and refrigerate at 2-8C. GHK-Cu is researched by dermatology departments, cosmetic science laboratories, and neuroscience institutions studying copper-dependent tissue repair and gene regulation.

GLOW

BPC Blend GLOW is a triple-peptide formulation combining BPC-157, GHK-Cu (copper peptide), and TB-500 at a total concentration of 70mg, designed for skin regeneration and cellular-aging research. Each component engages a distinct mechanism: BPC-157 promotes angiogenesis and tissue repair through VEGF/FGF upregulation; GHK-Cu activates collagen and elastin synthesis via copper-dependent enzyme modulation and TGF-beta signaling; TB-500 facilitates cell migration and anti-inflammatory activity through actin polymerization regulation. The inclusion of GHK-Cu is particularly relevant for dermal research, as studies by Pickart et al. (Journal of Cosmetic Dermatology, 2012) demonstrated that GHK-Cu stimulates dermal fibroblast proliferation, increases collagen type I and III synthesis, and modulates expression of over 4,000 human genes involved in tissue remodeling. Combined with the wound-healing properties of BPC-157 and the broad tissue-repair capabilities of TB-500, this three-peptide approach targets multiple phases of skin repair simultaneously: inflammation resolution, extracellular matrix rebuilding, and neovascularization. Compared to single-peptide or dual-peptide skin research formulations, the GLOW blend addresses both structural protein synthesis (via GHK-Cu) and vascular/cellular repair (via BPC-157 and TB-500). Store lyophilized powder at -20C protected from light due to copper peptide photosensitivity; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 14 days. This blend is studied by cosmetic dermatology research labs, wound healing centers, and aesthetic medicine research institutions investigating multi-peptide skin rejuvenation studies.

Frequently Asked Questions